Beli & Jual Ikapharmindo Putramas Tbk. - IKPM Hari Ini
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp363,57 M | -11.77% |
| Cost of Revenue | Rp213,86 M | -5% |
| Gross Profit | Rp149,7 M | -19.93% |
| General Expenses, Depreciation, Interest | Rp174,9 M | +3.28% |
| Operating Profit | -Rp25,2 M | -243.05% |
| Other Income | -Rp10,3 M | +7.49% |
| EBT | -Rp35,5 M | -541.79% |
| Taxes | Rp6,71 M | -322.25% |
| Net Income | -Rp28,78 M | -673.98% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp464 M | -5.57% |
| Total Liabilities | Rp245,26 M | +0% |
| Total Equity | Rp218,74 M | -11.13% |
| Total Liabilities & Total Equity | Rp464 M | -5.57% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp29,02 M | -182.27% |
| CF from Investment | Rp5,76 M | +92.7% |
| CF from Financing | Rp0 | -100% |
| Net Cash Flow | Rp23,25 M | -205.45% |